I have been invited by the chairman of the Tastforce European Baseline Series of the European Society of Contact Dermatitis to attend its meeting in September. An excellent opportunity to present a paper on why sorbitan sesquioleate should be included in the European baseline series. Pretty important, as the members of this Taskforce are the ones who decide on this issue.